Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals in the United States, Europe, the Asia Pacific, Mexico, Canada, and internationally. It operates in two segments, Specialty Alloys Operations and Performance Engineered Products. The company offers specialty alloys, including titanium alloys, powder metals, stainless steels, alloy steels, and tool steels, as well as additives, and metal powders and parts. It serves to aerospace, defense, medical, transportation, energy, industrial, and consumer markets. The company was founded in 1889 and is headquartered in Philadelphia, Pennsylvania.

Carpenter Technology Corporation

Caprice Resources Ltd. ( ($AU:CRS) ) has shared an announcement. Caprice Resources Ltd has announced successful assay results from its Phase 4 dril...

Caprice Resources Confirms Deep Gold Mineralization at Island Gold Project

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Crispr Therapeutics AG today and set a price target of $93.00. Accordi...

Bank of America Securities Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)

Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over the...

Crispr Therapeutics AG: Stock Surge Amid Challenges

The latest announcement is out from Crest Nicholson Holdings ( ($GB:CRST) ). Crest Nicholson Holdings plc has announced the appointment of Gillian ...

Crest Nicholson Director Appointed to Senior Role at STV Group

RBC Capital analyst Anthony Codling maintained a Buy rating on Crest Nicholson Holdings yesterday and set a price target of p205.00. According to T...

RBC Capital Keeps Their Buy Rating on Crest Nicholson Holdings (CRST)

Bernstein analyst William Pickering maintained a Hold rating on Crispr Therapeutics AG yesterday and set a price target of $43.00. The company’s sh...

Bernstein Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP)

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made a series of notable trades on Monday, December 1, according to daily fund disclosures. T...

ARKB, HOOD, SHOP, WRD: Cathie Wood Expands Crypto and AI Bets, Trims Stakes in Roku and GitLab (GTLB) Stocks

The latest announcement is out from Crest Nicholson Holdings ( ($GB:CRST) ). Crest Nicholson Holdings plc announced that as of 28 November 2025, it...

Crest Nicholson Updates Share Capital and Voting Rights

Caprice Resources Ltd. ( ($AU:CRS) ) has shared an announcement. Caprice Resources Ltd announced that all resolutions proposed at its Annual Genera...

Caprice Resources Ltd Successfully Passes All AGM Resolutions

Caprice Resources Ltd. ( ($AU:CRS) ) has shared an announcement. Caprice Resources Ltd. has presented its AGM presentation, highlighting its strate...

Caprice Resources Targets Major Gold Discovery in Murchison

Crispr Therapeutics AG ( ($CRSP) ) has fallen by -9.20%. Read on to learn why. Crispr Therapeutics AG has experienced a notable decline in its stoc...

Crispr Therapeutics AG Faces Stock Price Slide

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 20, as revealed in daily fun...

Cathie Wood Buys Nvidia, ACHR and Crypto Stocks, Offloads AMD, EXAS

The latest announcement is out from Carpenter Technology ( ($CRS) ). On November 20, 2025, Carpenter Technology Corporation completed a $700 millio...

Carpenter Technology Completes $700 Million Senior Notes Offering

In a report released yesterday, from Berenberg Bank reiterated a Hold rating on Crest Nicholson Holdings, with a price target of p180.00. The compa...

Crest Nicholson Holdings (CRST) Gets a Hold from Berenberg Bank

In a report released today, Rajesh Patki from Barclays maintained a Hold rating on Crest Nicholson Holdings, with a price target of £2.10. Accordin...

Barclays Remains a Hold on Crest Nicholson Holdings (CRST)

In a report released today, from Peel Hunt reiterated a Buy rating on Crest Nicholson Holdings, with a price target of p190.00. The word on The Str...

Peel Hunt Sticks to Its Buy Rating for Crest Nicholson Holdings (CRST)

Crispr Therapeutics ( ($CRSP) ) has released its Q3 earnings. Here is a breakdown of the information Crispr Therapeutics presented to its investors...

Market Cap	$15.36B	P/E Ratio	31.80
52W High	$342.11	52W Low	$138.61
Div Yield	80.0%	Payout Ratio	43.4%
EPS Growth 3Y	111.2%	52W Position	89.0%
Overall Score	53	Value Score	50
Quality Score	71	Technical Score	40

EPS Current Est	$10.05	EPS Next Est	$12.08
EPS Growth Est	+20.2%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CRS	$319.63	+4.94%	804.84K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CRS	$319.63	+4.9%	804.84K
3
4
5
6

CRS

CRS

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Carpenter Technology Corporation Data in Excel

Get Carpenter Technology Corporation Data in Excel